3,4-Dihydroxybenzalacetone (DBL) Prevents Aging-Induced Myocardial Changes in Senescence-Accelerated Mouse-Prone 8 (SAMP8) Mice

Aging is a predominant risk factor for the development and progression of cardiovascular complications. Physiologically and anatomically, the heart undergoes numerous changes that result in poor cardiac function in the elderly population. Recently, several studies have provided promising results, co...

Full description

Bibliographic Details
Main Authors: Vijayasree V. Giridharan, Vengadeshprabhu Karupppagounder, Somasundaram Arumugam, Yutaka Nakamura, Ashrith Guha, Tatiana Barichello, Joao Quevedo, Kenichi Watanabe, Tetsuya Konishi, Rajarajan A. Thandavarayan
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/3/597
_version_ 1797761708095176704
author Vijayasree V. Giridharan
Vengadeshprabhu Karupppagounder
Somasundaram Arumugam
Yutaka Nakamura
Ashrith Guha
Tatiana Barichello
Joao Quevedo
Kenichi Watanabe
Tetsuya Konishi
Rajarajan A. Thandavarayan
author_facet Vijayasree V. Giridharan
Vengadeshprabhu Karupppagounder
Somasundaram Arumugam
Yutaka Nakamura
Ashrith Guha
Tatiana Barichello
Joao Quevedo
Kenichi Watanabe
Tetsuya Konishi
Rajarajan A. Thandavarayan
author_sort Vijayasree V. Giridharan
collection DOAJ
description Aging is a predominant risk factor for the development and progression of cardiovascular complications. Physiologically and anatomically, the heart undergoes numerous changes that result in poor cardiac function in the elderly population. Recently, several studies have provided promising results, confirming the ability of the senescence-accelerated mouse-prone 8 (SAMP8) model to accurately model age-related cardiovascular alterations. In this study, using a murine model of senescence, SAMP8, we aimed to investigate the effect of 3,4-dihydroxybenzalacetone (DBL), a catechol-containing phenylpropanoid derivative isolated from <i>Inonotus</i><i> obliquus </i>(Chaga), on cardiac aging.<i> </i>DBL was administered at the doses of 10 mg/kg and 20 mg/kg by oral gavage to SAMP8 mice to examine aging-mediated cardiac changes, such as oxidative DNA damage, oxygen radical antioxidant capacity (ORAC) value, fibrosis, inflammation, and apoptosis. The treatment with DBL at both doses significantly reduced aging-mediated oxidative DNA damage, and simultaneously increased the ORAC value in the SAMP8 assay. Cardiac fibrosis was assessed with Azan-Mallory staining, and the number of cardiac remodeling markers was found to be significantly reduced after the treatment with DBL. We also observed a decrease in cardiomyocyte apoptosis as measured by the terminal transferase-mediated dUTP nick end labeling (TUNEL) staining method and the caspase-3 levels in SAMP8 mice compared with senescence-resistant control (SAMR1) mice. The findings from this study suggest that DBL has a potentially beneficial effect on aging-mediated myocardial alterations. Further studies are warranted to confirm the promising potential of this catechol compound against aging-associated myocardial dysfunction.
first_indexed 2024-03-12T19:16:55Z
format Article
id doaj.art-6425c74016394923877d0523003a4575
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-12T19:16:55Z
publishDate 2020-03-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-6425c74016394923877d0523003a45752023-08-02T05:28:33ZengMDPI AGCells2073-44092020-03-019359710.3390/cells9030597cells90305973,4-Dihydroxybenzalacetone (DBL) Prevents Aging-Induced Myocardial Changes in Senescence-Accelerated Mouse-Prone 8 (SAMP8) MiceVijayasree V. Giridharan0Vengadeshprabhu Karupppagounder1Somasundaram Arumugam2Yutaka Nakamura3Ashrith Guha4Tatiana Barichello5Joao Quevedo6Kenichi Watanabe7Tetsuya Konishi8Rajarajan A. Thandavarayan9Translational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054, USADepartment of Orthopedics and Rehabilitation, Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, USADepartment of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, 265-1, Higashijima, Akiha ku, Niigata 956-8603, JapanFaculty of Applied Life Sciences, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences Niigata, Niigata 956-8603, JapanDepartment of Cardiology, Houston Methodist Hospital, Houston, TX 77030, USATranslational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054, USATranslational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054, USADepartment of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, 265-1, Higashijima, Akiha ku, Niigata 956-8603, JapanNiigata University of Pharmacy & Applied Life Sciences (NUPALS), LIAISON R/D Center, Niigata 956-8603, JapanDepartment of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, 265-1, Higashijima, Akiha ku, Niigata 956-8603, JapanAging is a predominant risk factor for the development and progression of cardiovascular complications. Physiologically and anatomically, the heart undergoes numerous changes that result in poor cardiac function in the elderly population. Recently, several studies have provided promising results, confirming the ability of the senescence-accelerated mouse-prone 8 (SAMP8) model to accurately model age-related cardiovascular alterations. In this study, using a murine model of senescence, SAMP8, we aimed to investigate the effect of 3,4-dihydroxybenzalacetone (DBL), a catechol-containing phenylpropanoid derivative isolated from <i>Inonotus</i><i> obliquus </i>(Chaga), on cardiac aging.<i> </i>DBL was administered at the doses of 10 mg/kg and 20 mg/kg by oral gavage to SAMP8 mice to examine aging-mediated cardiac changes, such as oxidative DNA damage, oxygen radical antioxidant capacity (ORAC) value, fibrosis, inflammation, and apoptosis. The treatment with DBL at both doses significantly reduced aging-mediated oxidative DNA damage, and simultaneously increased the ORAC value in the SAMP8 assay. Cardiac fibrosis was assessed with Azan-Mallory staining, and the number of cardiac remodeling markers was found to be significantly reduced after the treatment with DBL. We also observed a decrease in cardiomyocyte apoptosis as measured by the terminal transferase-mediated dUTP nick end labeling (TUNEL) staining method and the caspase-3 levels in SAMP8 mice compared with senescence-resistant control (SAMR1) mice. The findings from this study suggest that DBL has a potentially beneficial effect on aging-mediated myocardial alterations. Further studies are warranted to confirm the promising potential of this catechol compound against aging-associated myocardial dysfunction.https://www.mdpi.com/2073-4409/9/3/5973,4-dihydroxybenzalacetonesamp8dna damagefibrosisapoptosis
spellingShingle Vijayasree V. Giridharan
Vengadeshprabhu Karupppagounder
Somasundaram Arumugam
Yutaka Nakamura
Ashrith Guha
Tatiana Barichello
Joao Quevedo
Kenichi Watanabe
Tetsuya Konishi
Rajarajan A. Thandavarayan
3,4-Dihydroxybenzalacetone (DBL) Prevents Aging-Induced Myocardial Changes in Senescence-Accelerated Mouse-Prone 8 (SAMP8) Mice
Cells
3,4-dihydroxybenzalacetone
samp8
dna damage
fibrosis
apoptosis
title 3,4-Dihydroxybenzalacetone (DBL) Prevents Aging-Induced Myocardial Changes in Senescence-Accelerated Mouse-Prone 8 (SAMP8) Mice
title_full 3,4-Dihydroxybenzalacetone (DBL) Prevents Aging-Induced Myocardial Changes in Senescence-Accelerated Mouse-Prone 8 (SAMP8) Mice
title_fullStr 3,4-Dihydroxybenzalacetone (DBL) Prevents Aging-Induced Myocardial Changes in Senescence-Accelerated Mouse-Prone 8 (SAMP8) Mice
title_full_unstemmed 3,4-Dihydroxybenzalacetone (DBL) Prevents Aging-Induced Myocardial Changes in Senescence-Accelerated Mouse-Prone 8 (SAMP8) Mice
title_short 3,4-Dihydroxybenzalacetone (DBL) Prevents Aging-Induced Myocardial Changes in Senescence-Accelerated Mouse-Prone 8 (SAMP8) Mice
title_sort 3 4 dihydroxybenzalacetone dbl prevents aging induced myocardial changes in senescence accelerated mouse prone 8 samp8 mice
topic 3,4-dihydroxybenzalacetone
samp8
dna damage
fibrosis
apoptosis
url https://www.mdpi.com/2073-4409/9/3/597
work_keys_str_mv AT vijayasreevgiridharan 34dihydroxybenzalacetonedblpreventsaginginducedmyocardialchangesinsenescenceacceleratedmouseprone8samp8mice
AT vengadeshprabhukarupppagounder 34dihydroxybenzalacetonedblpreventsaginginducedmyocardialchangesinsenescenceacceleratedmouseprone8samp8mice
AT somasundaramarumugam 34dihydroxybenzalacetonedblpreventsaginginducedmyocardialchangesinsenescenceacceleratedmouseprone8samp8mice
AT yutakanakamura 34dihydroxybenzalacetonedblpreventsaginginducedmyocardialchangesinsenescenceacceleratedmouseprone8samp8mice
AT ashrithguha 34dihydroxybenzalacetonedblpreventsaginginducedmyocardialchangesinsenescenceacceleratedmouseprone8samp8mice
AT tatianabarichello 34dihydroxybenzalacetonedblpreventsaginginducedmyocardialchangesinsenescenceacceleratedmouseprone8samp8mice
AT joaoquevedo 34dihydroxybenzalacetonedblpreventsaginginducedmyocardialchangesinsenescenceacceleratedmouseprone8samp8mice
AT kenichiwatanabe 34dihydroxybenzalacetonedblpreventsaginginducedmyocardialchangesinsenescenceacceleratedmouseprone8samp8mice
AT tetsuyakonishi 34dihydroxybenzalacetonedblpreventsaginginducedmyocardialchangesinsenescenceacceleratedmouseprone8samp8mice
AT rajarajanathandavarayan 34dihydroxybenzalacetonedblpreventsaginginducedmyocardialchangesinsenescenceacceleratedmouseprone8samp8mice